A phase I/Il Study of erlotinib (Tarceva) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (HNSCC).
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 1, 2003
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Clinical Cancer Research Journal